A Study To Evaluate Escalating Doses of A Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC

Conditions:   Non-Small Cell Lung Cancer;   Triple-negative Breast Cancer Intervention:   Biological: PF-06936308 Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials